Sooryanarayana Varambally

Author

Also Known As

Arul M. Chinnaiyan, Nirag C Jhala, R J Lonigro, S Varambally, S. Varambally, Sooryanarayana Varambally, Sooryanarayanan Varambally, Soorynarayana Varambally

410

Publications

42.4K

Citations

H-Index

110

Concepts

All Affiliations

University of Michigan University of Alabama at Birmingham Michigan Center for Translational Pathology Howard Hughes Medical Institute Dana-Farber Cancer Institute

About

Sooryanarayana Varambally is an author at University of Michigan specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	59	23.7K
2	Engineering	7	7	7.6K
3	Natural Sciences	3	3	296
4	Health Sciences	2	2	68
5	Allergy	2	2	33

Sooryanarayana Varambally

125

Publications

40.5K

Citations

H-Index

Page 1

	Year	Citations
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses Darshan S. Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya, Neoplasia	2017	6.4K
Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Cancer Scott A. Tomlins, Daniel R. Rhodes, Sven Perner, Science Outlier Gene ExpressionEngineeringGeneticsMolecular BiologyRecurrent Fusion	2005	3.8K
The polycomb group protein EZH2 is involved in progression of prostate cancer Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou, Nature Tumor BiologyChromatinChromatin StructureMedicineTumor Suppressor	2002	2.7K
UALCAN: An update to the integrated cancer data analysis platform Darshan S. Chandrashekar, Santhosh Kumar Karthikeyan, Praveen Kumar Korla, Neoplasia EngineeringPathologyCancer RegistrationBioinformatics DatabaseCancer Genomic	2022	2.3K
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Arun Sreekumar, Laila Poisson, Thekkelnaycke M. Rajendiran, Nature MedicineMetabolomic ProfilingCancer GenomicsPotential RoleCancer Biology	2009	2.2K
Delineation of prognostic biomarkers in prostate cancer Saravana M. Dhanasekaran, Terrence R. Barrette, Debashis Ghosh, Nature Prognostic BiomarkersUrologyOncologyMedicineBiomarker Target	2001	1.7K
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer Himisha Beltran, Davide Prandi, Juan Miguel Mosquera, Nature Medicine Endocrine-related CancerUrologyProstatic DiseaseDivergent Clonal Evolution	2016	1.7K
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Celina G. Kleer, Qi Cao, Sooryanarayana Varambally, Proceedings of the National Academy of Sciences Breast OncologyPathologyCancer BiologyEpigeneticsTumor Biology	2003	1.6K
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer Sooryanarayana Varambally, Qi Cao, Ram S. Mani, Science Histone ModificationsEpigenetic ChangeMicrorna-101 LeadsEpigeneticsTumor Biology	2008	1.1K
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression Jindan Yu, Jianjun Yu, Ram S. Mani, Cancer Cell Androgen ReceptorIntegrated NetworkCancer GenomicsProstate Cancer ProgressionProstatic Disease	2010	844

Page 1